Joshua Brumm
2019 - Dyne Therapeutics
In 2019, Joshua Brumm earned a total compensation of $277.3K as President and Chief Executive Officer at Dyne Therapeutics.
Compensation breakdown
| Bonus | $180,000 |
|---|---|
| Salary | $97,212 |
| Other | $102 |
| Total | $277,314 |
Brumm received $180K in bonus, accounting for 65% of the total pay in 2019.
Brumm also received $97.2K in salary and $102 in other compensation.
Rankings
In 2019, Joshua Brumm's compensation ranked 13,063rd out of 13,971 executives tracked by ExecPay. In other words, Brumm earned more than 6.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 13,063 out of 13,971 | 7th |
Division Manufacturing | 5,305 out of 5,695 | 7th |
Major group Chemicals And Allied Products | 2,069 out of 2,194 | 6th |
Industry group Drugs | 1,779 out of 1,880 | 5th |
Industry Pharmaceutical Preparations | 1,312 out of 1,392 | 6th |
Source: SEC filing on April 14, 2021.
Brumm's colleagues
We found one more compensation record of an executive who worked with Joshua Brumm at Dyne Therapeutics in 2019.
2019
Romesh Subramanian
Dyne Therapeutics
Chief Scientific Officer
News
Dyne Therapeutics CEO Joshua Brumm's 2022 pay rises 6% to $4.3M
April 7, 2023
Dyne Therapeutics CEO Joshua Brumm's 2021 pay falls 66% to $4.1M
April 22, 2022
Dyne Therapeutics CEO Joshua Brumm's 2020 pay jumps 981% to $12M
April 14, 2021
Kaleido Biosciences CEO Alison Lawton's 2019 pay falls 57% to $2.9M
May 8, 2020